Effect of glucose variability on the mortality of adults aged 75 years and over during the first year of the COVID-19 pandemic.
Miguel Ángel Salinero-FortF Javier San Andrés-RebolloJuan Cárdenas-ValladolidJosé MostazaCarlos LahozFernando Rodriguez-ArtalejoPaloma Gómez-CampeloPilar Vich-PérezRodrigo Jiménez-GarcíaJosé M de-Miguel-YanesJavier Maroto-RodriguezBelén Taulero-EscaleraVíctor Iriarte Camponull nullPublished in: BMC geriatrics (2024)
GV has clear implications for clinical practice, as its assessment as a risk prediction tool should be included in the routine follow-up of the elderly and in a comprehensive geriatric assessment. Electronic health records can incorporate tools that allow its calculation, and with this information, clinicians will have a broader view of the medium- and long-term prognosis of their patients.
Keyphrases
- electronic health record
- clinical practice
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- palliative care
- prognostic factors
- cardiovascular events
- peritoneal dialysis
- type diabetes
- healthcare
- adipose tissue
- middle aged
- blood pressure
- cardiovascular disease
- blood glucose
- patient reported outcomes
- insulin resistance
- weight loss
- social media
- clinical evaluation